Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. (Q33767866)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. |
scientific article |
Statements
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group (English)
G J Bubley
M Carducci
W Dahut
N Dawson
D Daliani
M Eisenberger
W D Figg
B Freidlin
G Hudes
M Hussain
R Kaplan
C Myers
W Oh
D P Petrylak
E Reed
B Roth
O Sartor
H Scher
J Simons
V Sinibaldi
M R Smith
D L Trump
1 November 1999